MARLBOROUGH, Mass.,
Sept. 21, 2018 /PRNewswire/
-- Boston Scientific Corporation (NYSE: BSX) today announced
the global launch of the LithoVue Empower™ Retrieval Deployment
Device, designed to be used with the LithoVue™ Single-Use Digital
Flexible Ureteroscope and compatible nitinol retrieval basket to
enable urologists to operate a ureteroscope and basket
simultaneously when retrieving kidney stones via flexible
ureteroscopy (URS). The LithoVue Empower Device is one of several
new devices Boston Scientific is planning that addresses unmet
needs and inefficiencies during stone procedures through
innovation.
Experience the interactive Multichannel News Release here:
https://www.multivu.com/players/English/8297353-boston-scientific-lithovue-empower-retrieval-deployment-device/
Until now, urologists have traditionally relied on another
person during kidney stone retrieval to operate the basket used to
collect kidney stones. Turning a two-person stone basketing
procedure into a single-person procedure provides greater control
for the surgeon, decreasing the risk of miscommunication during
stone basketing without compromising time.1
"The LithoVue Empower Device is a unique tool that can improve
ureteroscopic stone treatment as it puts the process of stone
manipulation entirely into the hands of the surgeon," said Dr.
Brian Matlaga, the Stephens
Professor of Urology at Johns Hopkins Medical Institutions and
director of stone disease, James Buchanan Brady Urological
Institute and presenting author of the data. "Ultimately, the
LithoVue Empower Device introduces a novel efficiency into
ureteroscopic stone surgery, as it makes it simpler for the
urologist to pick up and move a stone – a historic source of
frustration for this procedure."
Data presented in a poster today by Dr. Kevin Koo, fellow at Johns Hopkins Medical
Institutions and James Buchanan Brady Urological Institute, showed
the LithoVue Empower Device permitted a single surgeon to perform
flexible ureteroscopy with stone manipulation and retrieval, using
less muscular workload than a single-surgeon ureteroscopy (i.e.,
where a single surgeon has to operate both the ureteroscope and
retrieval tool) and similar workload to two-surgeon ureteroscopy.
Task completion time was also improved with LithoVue Empower over
the single-surgeon model and similar to the two-surgeon model.
Using an observational research method called ethnography,
Boston Scientific deployed research teams into operating rooms
(ORs) around the world to study how flexible ureteroscopy and
percutaneous nephrolithotomy (PCNL) procedures are being conducted
and how they can be improved. A powerful insight gained from this
research is that, with stone retrieval specifically, increasing
surgeon control and reducing the effort required to coordinate
people, tools and movements is important to urologic
surgeons.2 The research showed that retrieving kidney
stones is one of the most time-consuming steps during ureteroscopy
procedures, making this an opportune area to improve physician
control, address communication/coordination challenges and identify
time savings.
"The LithoVue Empower Device was developed in direct response to
a need to improve procedural bottlenecks during kidney stone
removal procedures," said David
Pierce, executive vice president and president, MedSurg,
Boston Scientific. "We are committed to identifying and addressing
unmet needs to enable healthcare providers to advance patient
outcomes, reduce procedural costs, enhance quality of care and
evolve the treatment of urologic and pelvic conditions."
The LithoVue Empower Device is immediately available in the U.S.
and Europe. For more product and
important safety information, please visit
www.bostonscientific.com/LithoVueEmpower or follow Boston
Scientific Urology and Pelvic Health on Twitter.
About Boston Scientific
Boston Scientific
transforms lives through innovative medical solutions that improve
the health of patients around the world. As a global medical
technology leader for more than 35 years, we advance science for
life by providing a broad range of high performance solutions that
address unmet patient needs and reduce the cost of healthcare. For
more information, visit www.bostonscientific.com and connect on
Twitter and Facebook.
Cautionary Statement Regarding Forward-Looking
Statements
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Forward-looking statements may be identified by words
like "anticipate," "expect," "project," "believe," "plan,"
"estimate," "intend" and similar words. These forward-looking
statements are based on our beliefs, assumptions and estimates
using information available to us at the time and are not intended
to be guarantees of future events or performance. These
forward-looking statements include, among other things, statements
regarding our product launches and product performance and impact.
If our underlying assumptions turn out to be incorrect, or if
certain risks or uncertainties materialize, actual results could
vary materially from the expectations and projections expressed or
implied by our forward-looking statements. These factors, in some
cases, have affected and in the future (together with other
factors) could affect our ability to implement our business
strategy and may cause actual results to differ materially from
those contemplated by the statements expressed in this press
release. As a result, readers are cautioned not to place undue
reliance on any of our forward-looking statements.
Factors that may cause such differences include, among other
things: future economic, competitive, reimbursement and regulatory
conditions; new product introductions; demographic trends; the
closing and integration of acquisitions; intellectual property;
litigation; financial market conditions; and future business
decisions made by us and our competitors. All of these factors are
difficult or impossible to predict accurately and many of them are
beyond our control. For a further list and description of these and
other important risks and uncertainties that may affect our future
operations, see Part I, Item 1A – Risk Factors in our most
recent Annual Report on Form 10-K filed with the Securities and
Exchange Commission, which we may update in Part II, Item 1A –
Risk Factors in Quarterly Reports on Form 10-Q we have filed
or will file hereafter. We disclaim any intention or obligation to
publicly update or revise any forward-looking statements to reflect
any change in our expectations or in events, conditions or
circumstances on which those expectations may be based, or that may
affect the likelihood that actual results will differ from those
contained in the forward-looking statements. This cautionary
statement is applicable to all forward-looking statements contained
in this document.
CONTACTS
Trish Backes
Media Relations
651-582-5887 (office)
Trish.Backes@bsci.com
Susie Lisa, CFA
Investor Relations
508-683-5565 (office)
BSXInvestorRelations@bsci.com
1 Joice GA, Ludwig WW, Schwen ZR, et al. Ergonomics
and procedure time of novel retrieval deployment device for single
surgeon ureteroscopy. Abstract presented at EUS Annual Meeting,
May 18, 2018, San Francisco, CA.
2 Data on file with Boston Scientific.
View original
content:http://www.prnewswire.com/news-releases/boston-scientific-launches-lithovue-empower-retrieval-deployment-device-300716711.html
SOURCE Boston Scientific Corporation